PureCycle Technologies (PCT) Q1 2025 earnings summary

Executive summary

• Achieved first reported revenues of $1.6 million in Q1 2025, marking a significant operational milestone and validating commercial progress across multiple end markets and product types.

• Operational improvements at Ironton led to nearly 90% on-stream time in April, with record monthly pellet production and improved reliability.

• Engaged in over 30 active customer trials, with 24 in the industrial phase and continued collaboration with major partners such as Procter & Gamble.

• Early successes in fiber, film, and automotive applications, including a breakthrough with Brückner in BOPP film and first commercial sale to Drake Extrusion.

• Expanded product offerings with new PureFive Choice and Ultra grades for diverse applications.

Financial highlights

• Reported Q1 2025 revenue of $1.6 million, up from $0 in Q1 2024.

• Ended the quarter with $37.5 million in cash, including $22.5 million unrestricted.

• Raised over $59 million during the quarter through equity and revenue bond sales, with an additional $11.8 million in bonds sold after quarter-end.

• Operations and corporate spend totaled $37 million for the quarter, consistent with the prior year.

• Produced 4.3 million lbs of resin and held approximately 14 million lbs of inventory at quarter-end.

Outlook and guidance

• Expects commercial ramp to accelerate in the second half of 2025 as product trials convert to sales, with increased sales from customer trials and higher-value branded sales.

• Targeting break-even at Ironton by Q3 2025 and aiming to reduce corporate cash burn into early 2026.

• Planning aggressive capacity expansion for future lines, leveraging operational learnings to improve CapEx and OpEx efficiency.

• Augusta Facility construction and financing timeline remains uncertain due to market conditions; company is limiting expenses and adjusting project schedule accordingly.

• Additional debt or equity financing likely needed for future growth and investment.